Lv4
480 积分 2025-08-21 加入
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
1天前
待确认
Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer
30天前
已完结
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
30天前
已完结
Neutrophil diversity and plasticity in tumour progression and therapy
4个月前
已完结
Breast cancer
4个月前
已完结
Global analysis of advanced/metastatic breast cancer: Decade report (2005–2015)
4个月前
已完结
Associations between Pregnane X Receptor and Breast Cancer Growth and Progression
4个月前
已完结
Serum, plasma and saliva biomarkers for head and neck cancer
5个月前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
5个月前
已完结
A microprotein encoded by LINC00263 promotes breast cancer osteolytic bone metastasis by inducing osteoclastogenesis and inhibiting osteoclast ferroptosis
9个月前
已完结
皖公网安备34019202002308
